Comparison of the Effects of Enoxaparin and Heparin on Inflammatory Biomarkers in Patients with ST-segment Elevated Myocardial Infarction: A prospective Open Label Pilot Clinical Trial
| Author | Somayyeh Nasiripour | en |
| Author | kheirollah Gholami | en |
| Author | Sarah Mousavi | en |
| Author | Abbas Mohagheghi | en |
| Author | Mania Radfar | en |
| Author | Mohammad Abdollahi | en |
| Author | Zahra Khazaeipour | en |
| Author | Mojtaba Mojtahedzadeh | en |
| Issued Date | 2014-04-30 | en |
| Abstract | Heparin and enoxaparin possess anti-inflammatory properties. We compared the effects of these drugs on inflammatory biomarkers in patients with ST-segment Elevated Myocardial Infarction (STEMI). | en |
| DOI | https://doi.org/10.22037/ijpr.2014.1513 | en |
| Keyword | Heparin | en |
| Keyword | Enoxaparin | en |
| Keyword | Acute coronary syndrome | en |
| Keyword | STEMI | en |
| Keyword | Inflammatory biomarkers | en |
| Publisher | Brieflands | en |
| Title | Comparison of the Effects of Enoxaparin and Heparin on Inflammatory Biomarkers in Patients with ST-segment Elevated Myocardial Infarction: A prospective Open Label Pilot Clinical Trial | en |
| Type | Original Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- ijpr-13-583.pdf
- Size:
- 719.28 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF